Clinical Trial Update: Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acalabrutinib combined with R-miniCHOP in older adults with untreated diffuse large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• R-miniCHOP (undefined)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma | Phase 3 | Status: RECRUITING